YIM Oral

1016 - Integrating phosphoproteomic analysis and innovative 3D cell culture systems to dissect the role of extracellular stiffness in CLL pathogenesis

1017 - Long Non-Coding RNA LINC00173 Regulates BCR Signaling Propensity and mRNA Translation via Ribonucleoprotein Granules in CLL Cells

1022 - Unravelling the Clinical and Biological Features of Accelerated Chronic Lymphocytic Leukemia

1201 - IFNγ/IL21-JAK-STAT1 Signaling Axis Drives T-Cell–Mediated CLL Proliferation and Venetoclax Resistance

1203 - SF3B1 K700E Mutation Promotes SAT1-Mediated Metabolic Reprogramming and Suppresses T-cell Immune Response in Chronic Lymphocytic Leukemia

1209 - Early effects of venetoclax monotherapy on immune cells in patients with chronic lymphocytic leukemia

1503 - Analysis of resistance-related mutations in patients with Chronic Lymphocytic Leukemia treated with BTK or BCL2 inhibitors suggests different underlying resistance mechanisms and subclonal dynamics

1601 - Central Nervous System Involvement in Patients with Richter Transformation

1602 - Venetoclax in combination with chemotherapy in Richter Syndrome patients: a real-life experience

1603 - Single-cell transcriptome analysis reveals molecular mechanism of stem-like cells in Richter Transformation

1801 - Targeting BTKi-Resistant CLL Using the Dual Irreversible/Reversible 4th Generation BTK Inhibitor Rocbrutinib

1802 - Targeting SF3B1 Disrupts Chronic Lymphocytic Leukemia Survival via PFKFB-mediated Glycolytic Dependency